Research News and Research

RSS

Eye drops to slow the progression of nearsightedness in kids could be on the horizon

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.

1 Jun 2023

MU biologist receives NIH grant to develop a better understanding of complex genetic traits

Driven by a lifelong curiosity about the natural world and the diversity of life, Elizabeth King, associate professor in the Division of Biological Sciences at the University of Missouri, found inspiration to spend her formative years studying science - and along the way she discovered her passion for biology.

1 Jun 2023

Juicy findings: Chinese consumers embrace fruit peel delights, scientists examine nutritional value and pesticide concerns

Research explores the consumption of fruit peels by Chinese consumers, highlighting their nutritional value and pesticide residues. It provides insights into methods of pesticide detection and removal, as well as the physiological benefits of fruit peels, aiming to guide informed consumption and contribute to further research in this area.

1 Jun 2023

Scientists investigate how immune system's T cells could fight many coronaviruses at once

Scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system's T cells react to a wide variety of coronaviruses, ranging from SARS to common cold coronaviruses.

1 Jun 2023

RNA regulatory mechanism could be targeted to slow AD progression mediated by stress granules

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 10, entitled, "Stress granules sequester Alzheimer's disease-associated gene transcripts and regulate disease-related neuronal proteostasis."

1 Jun 2023

St. Jude researchers discover NLRP12 as a direct bridge from hemolysis to inflammatory disease

Infections and other diseases can cause red blood cells to rupture, releasing the oxygen-binding molecule hemoglobin, which breaks down into heme.

1 Jun 2023

Artificial viral vectors constructed from bacteriophage T4 show promise for advanced gene delivery

Research presents an assembly-line approach using bacteriophage T4 components to construct artificial viral vectors (AVVs). These AVVs have the potential to revolutionize gene therapies and personalized medicine by enabling the efficient delivery of biomolecules for molecular repairs and genome remodeling.

1 Jun 2023

The debt ceiling deal takes a bite out of health programs. It could have been much worse.

Policy analysts, Democrats, and Republicans dissatisfied with the deal agree: Federal health programs have dodged a budgetary bullet in the Washington showdown over raising the nation's debt ceiling.

1 Jun 2023

New algorithm could improve the search for genetic cause of hereditary diseases

So far, it has not been possible to explain the causes of around half of all rare hereditary diseases. A Munich research team has developed an algorithm that predicts the effects of genetic mutations on RNA formation six times more precisely than previous models.

1 Jun 2023

Fentanyl could be weaponized and used for terroristic mass poisoning

The widely-available drug fentanyl, already the number one killer of Americans under 50, could be weaponized and used for terroristic mass poisoning, according to health experts at Rutgers and other institutions.

1 Jun 2023

Technology advance could enable the use of ophthalmologic OCT systems at home

Researchers have shown that a vertical cavity surface emitting laser (VCSEL) diode, which is commonly used in telecommunications and lidar applications, could offer a less expensive light source for swept-source optical coherence tomography (OCT).

1 Jun 2023

NCI launches new initiative to test new drug combinations that target specific tumor alterations

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations.

1 Jun 2023

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

he National Comprehensive Cancer Network - a not-for-profit alliance of leading cancer centers in the United States - today announced the signing of a Memo of Understanding (MOU) with Vietnam National Cancer Hospital ("K Hospital") and the Vietnam Cancer Association to work together to improve standards for cancer care throughout the country.

1 Jun 2023

New genetic risk factors for Alzheimer’s disease unique to Ashkenazi Jews identified

Alzheimer disease (AD), the most common neurodegenerative disorder in the world, affects individuals of all races and ethnicities; however, most genetic research for AD has been performed on individuals of European ancestry (EA) with a limited number of large-scale genetic studies in other populations.

1 Jun 2023

Recurrent cases of ocular toxoplasmosis more likely to occur in women

Women are more likely to experience recurrent cases of the Toxoplasma parasite, according to new Flinders University research.

1 Jun 2023

Long-term side effects of modern treatment for rheumatoid arthritis

Janus kinase inhibitors (JAKi) and biologics are the cornerstone of modern treatment for rheumatoid arthritis (RA). But there have been concerns over long-term side effects.

1 Jun 2023

EULAR launches unique resource of facts and figures related to RMDs across Europe

The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of RheumaFacts, an innovative and unique resource of facts and figures related to rheumatic and musculoskeletal diseases (RMDs) across Europe.

1 Jun 2023

EULAR announces the launch of new survey targeted directly at RMD patients

The European Alliance of Associations for Rheumatology has announced the launch of the EULAR Impact of RMDs Survey, an online questionnaire targeted directly at RMD patients.

1 Jun 2023

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles.

1 Jun 2023

"Deep sequencing" of the genome informs diagnoses and treatment of vascular anomalies

Researchers from Children's Hospital of Philadelphia (CHOP) recently discovered that extremely thorough "deep sequencing" of the genome in tissue samples and cell-free DNA of patients with potentially life-threatening vascular anomalies captured several genetic variants related to disease that were not captured with conventional genetic sequencing methods.

1 Jun 2023

Research News and Research

Eye drops to slow the progression of nearsightedness in kids could be on the horizon

MU biologist receives NIH grant to develop a better understanding of complex genetic traits

Juicy findings: Chinese consumers embrace fruit peel delights, scientists examine nutritional value and pesticide concerns

Scientists investigate how immune system's T cells could fight many coronaviruses at once

RNA regulatory mechanism could be targeted to slow AD progression mediated by stress granules

St. Jude researchers discover NLRP12 as a direct bridge from hemolysis to inflammatory disease

Artificial viral vectors constructed from bacteriophage T4 show promise for advanced gene delivery

The debt ceiling deal takes a bite out of health programs. It could have been much worse.

New algorithm could improve the search for genetic cause of hereditary diseases

Fentanyl could be weaponized and used for terroristic mass poisoning

Technology advance could enable the use of ophthalmologic OCT systems at home

NCI launches new initiative to test new drug combinations that target specific tumor alterations

NCCN collaborates with K Hospital and Vietnam Cancer Association to improve standards for cancer care

New genetic risk factors for Alzheimer’s disease unique to Ashkenazi Jews identified

Recurrent cases of ocular toxoplasmosis more likely to occur in women

Long-term side effects of modern treatment for rheumatoid arthritis

EULAR launches unique resource of facts and figures related to RMDs across Europe

EULAR announces the launch of new survey targeted directly at RMD patients

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

"Deep sequencing" of the genome informs diagnoses and treatment of vascular anomalies

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring